MétaCan
Menu
← Back to cohort
Record W4251831405 · doi:10.1200/jco.2004.22.90140.524

Adverse association of expressed vascular endothelial growth factor (VEGF) with long-term outcome of stage I-III breast cancer (BrCa), with co-expression data of VEGF and Her2, Cox2, uPA and ER. Results from the British Columbia Tissue Microarray Project

2004· article· en· W4251831405 on OpenAlexaffabout
Joseph Ragaz, Kathy D. Miller, Sunil Badve, Y. Dayachko, Sally Dunn, Torsten Holm Nielsen, A. Brodie, David Huntsman, Chris Bajdik, G. W. Sledge

Bibliographic record

VenueJournal of Clinical Oncology · 2004
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicBreast Cancer Treatment Studies
Canadian institutionsMcGill UniversityUniversity of British Columbia Hospital
Fundersnot available
KeywordsMedicineImmunohistochemistryTissue microarrayBreast cancerStage (stratigraphy)Internal medicineVascular endothelial growth factorOncologyCancerConfidence intervalAngiogenesisVEGF receptorsPathologyBiology

Abstract

fetched live from OpenAlex

524 Background. Several prior studies have shown association of VEGF with inferior outcome of BrCa. However, only a few past studies had a large number of patients, or availability of multiple markers and prognostic factors.Methods. In this study, impact of VEGF was correlated with the outcome in a large cohort of Breast Cancer (BrCa) patients, enrolled between 1978–1990 in phase II-III British Columbia trials, who had tissue microarrays (TMA) built from paraffin, with 877 pts having VEGF expression tested by Immunohistochemistry (IHC, Biogenix polyclonal anti-VEGF Ab, Dako). For detection, the LSAB2 kit with the DAB as the chromogen, was used. Event at 15 years was any death (expressed as OS%), with the median survival and 95% confidence intervals (CI) expressed for 4 groups according to the stain intensity. Other markers (Her2, Cox2, uPA, ER, etc.) were tested for co-expression. Results. At a median follow up of 17.4 years (ranges 9.8, 28.7 years), 586 patients died (any death), and 502 had BrCa recurrence. Expression of VEGF showed progressively worse outcome according to intensity of expression. VEGF expression showed a positive coexpression with Her2 (49 vs 61% for Her2-ve vs +ve, p=0.006); Cox2 (47 vs 57%, for −ve vs +ve, p=0.004); uPA (43 vs 59%, for −ve vs +ve, p<0.001) and a negative coexpression with ER (55 vs 47%, for −ve vs +ve).Conclusion: Expression of VEGF, and its intensity, are associated with a significantly inferior outcome of early BrCa, and with co-expression of several markers of relevance in BrCa biology. VEGF, Her2, Cox2 and other markers can be successfully tested on TMA permitting interactive testing of multiple markers. These data indicate that diagnostic and therapeutic trials exploiting VEGF expression interacting with other markers are indicated for early BrCa. No significant financial relationships to disclose.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.001
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.016
Threshold uncertainty score0.032

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.046
GPT teacher head0.376
Teacher spread0.330 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations3
Published2004
Admission routes2
Has abstractyes

Explore more

Same venueJournal of Clinical Oncology→Same topicBreast Cancer Treatment Studies→French-language works237,207→